. "4. Comparison of Disease Burdens and Costs." New Vaccine Development: Establishing Priorities: Volume I, Diseases of Importance in the United States. Washington, DC: The National Academies Press, 1985.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
New Vaccine Development Establishing Priorities, Volume I: Diseases of Importance in the United States
Comparison of Disease Burdens and Costs
The objective of any vaccine development program is to reduce morbidity, mortality, and costs resulting from disease. Unfortunately, time and resource limitations make it impossible to pursue intensive development programs for all vaccines simultaneously. Priorities must be set in a manner that is consistent both with the needs of the population and the capabilities of current technologies. The committee sought a methodology that would allow quantitative comparison of the burdens of morbidity and mortality resulting from disease candidates for accelerated vaccine development.
In the proposed system, information on morbidity and mortality are combined into a single numerical score for each disease.* The same principles have been used to calculate the expected health benefits from individual vaccine candidates in Chapter 7. Application of the system to diseases that are candidates for long-term rather than accelerated development is discussed in Appendix B.
The methods used to calculate and compare the costs associated with the diseases are described in the latter portion of this chapter, and the cost savings that may be achieved from the vaccines are presented in Chapter 7.
Elements of the System for Comparing Morbidity and Mortality Burdens Arising From various Diseases
The system described below was designed not only to incorporate information relating to a disease (i.e., incidence, severity, complications, sequelae, duration, and distribution), but also to allow expression of individual value judgments on the undesirability (disutility) of different consequences resulting from that disease. Such value judgments are an inevitable part of the ranking process, whether they are explicit or implicit. The committee chose to make them explicit.
See Appendix R for information on the computer software used in this analysis.
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole. Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.